Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Parenteral nutrition

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Synopsis

Use parenteral nutrition only for a defined gastrointestinal failure, prescribe a complete individual admixture safely, and prevent catheter, metabolic, hepatic and refeeding complications through specialist monitoring.

  • Parenteral nutrition is indicated when oral and enteral routes are unsafe, inadequate or impossible because the gastrointestinal tract cannot absorb or be accessed sufficiently; it is not a shortcut around feeding difficulties.
  • Define the intestinal problem, expected duration, treatment goal and exit strategy before insertion of vascular access, involving the nutrition-support team early.
  • A complete prescription accounts for energy, amino acids, glucose, lipid, electrolytes, vitamins, trace elements and fluid, with daily individualisation during unstable illness.
  • Central venous access permits more concentrated long-term delivery; peripheral PN is limited by venous tolerance, composition and duration and remains subject to the same metabolic safeguards.
  • Use a dedicated lumen and strict aseptic technique, minimising manipulation; never connect incompatible medicines or sample blood routinely through a PN line outside the agreed policy.
  • Identify refeeding risk before the first bag, give vitamin support, initiate energy cautiously and monitor phosphate, potassium, magnesium, glucose and fluid balance.
  • Suspected catheter-related bloodstream infection requires paired appropriately labelled cultures and early microbiology or intestinal-failure advice; shock needs immediate treatment, while line removal depends on organism and clinical context.
  • Return to oral or enteral intake whenever useful gut function recovers, reducing PN in a controlled manner rather than maintaining intravenous calories through clinical inertia.

Key red flags

Rigors with hypotension, confusion, mottling or lactate elevation in a patient with central access requires immediate sepsis treatment after cultures when safe and must not await proof of line infection.

Sudden chest pain, dyspnoea, arrhythmia or cardiovascular collapse during line insertion or manipulation suggests pneumothorax, embolic or malposition complications requiring emergency response.

Rapid oedema, heart failure, respiratory weakness, delirium or arrhythmia after nutrition begins may indicate severe refeeding physiology and demands urgent correction.

Painful swollen limb or face with catheter dysfunction suggests central venous thrombosis; preserve future access by seeking specialist imaging and anticoagulation advice promptly.

Marked hyperglycaemia with ketones, hyperosmolar symptoms or reduced consciousness is a medical emergency, not simply a reason to discard the current PN bag.

Investigation priorities

01
Nutrition and intestinal-failure assessmentFirst step

Confirm indication, estimate requirements and identify a feasible route transition.

Management branches

INDICATEDecision to start PN

Nutrition goals cannot be met safely through oral or enteral routes because gut function or access is inadequate.

  1. Define the gastrointestinal mechanism, predicted duration, prior route optimisation, refeeding category and patient-centred objective.
  2. Refer to the multidisciplinary nutrition-support team to estimate requirements and choose peripheral or central access with a documented rationale.
  3. Establish baseline biochemistry, fluid balance, vascular-access plan and aseptic responsibilities before ordering the tailored formulation.
  4. Set review criteria for progression, complication surveillance and transition back toward gastrointestinal feeding.

Key medicines

Individualised parenteral nutrition admixtureInfuse the pharmacy-approved daily formulation through the designated access at the prescribed rate and duration, using a pump and aseptic connection.Never add bedside ingredients or run incompatible drugs through the dedicated lumen; account for refeeding risk, organ failure, glucose, triglycerides, fluid status and formulation stability.
Thiamine and multivitamin preparationProvide before and during initial nutritional escalation according to refeeding risk, route reliability and the local nutrition protocol.Ensure the complete PN prescription contains ongoing vitamins and trace elements where indicated; replacement does not remove the need for controlled energy and electrolyte monitoring.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG32 Nutrition support recommendationsNational indications, prescription and monitoring principles for PN.
  • NHS England intestinal failure PN specificationSpecialised service requirements for type 2 and type 3 intestinal failure.
  • BIFA guidelines hubUK intestinal-failure professional guidance and practical safety resources.
  • BIFA CRBSI diagnosis recommendationsUpdated paired-culture and catheter infection diagnostic practice.
  • BAPEN PN complication managementClinical framework for line, metabolic and hepatic complications.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom